Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468084 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL29957453 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL1007447 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL25933046 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| Hydrochloric Acid SCHEMBL11095114 | 0.96 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL4632980 | 0.96 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL4633860 | 0.96 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL28153656 | 0.89 | SLC7A5 (0.53) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL3930054 | 0.86 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL5326967 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12576169-B2 | Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof | Technische Universität München (DE) | 2026-03-17 | — | — | US | claimed |
| EP-4650469-A1 | PROCESS FOR ELECTROMEDIATED METAL STRIPPING AND RECOVERY | UNIVERSITE CLAUDE BERNARD - LYON 1 (FR) | 2025-11-19 | — | — | EP | claimed |
| CN-119912365-A | Taurine refining process and application thereof | 江阴华昌食品添加剂有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-118852828-A | High-density polyethylene composite material for corrugated pipe and preparation method thereof | 埃维勒（北京）化工科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118146465-A | Bio-based hydrogel particle and preparation method and application thereof | 周口师范学院 | 2024-06-07 | — | — | CN | claimed |
| CN-118126265-A | High-temperature-resistant salt-resistant bio-based hydrogel particle as well as preparation method and application thereof | 周口师范学院 | 2024-06-04 | — | — | CN | claimed |
| CN-118085782-A | Preparation method of double-network reinforced and toughened environment-friendly adhesive | 河南农业大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117603411-A | Bio-based hydrogel particle and preparation method and application thereof | 安徽古井贡酒股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117004350-A | High-temperature-resistant high-humidity UV (ultraviolet) glue reducing adhesive tape | 北京序轮科技有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116589637-A | Profile control water shutoff agent and preparation method and application thereof | 中国石油大学(华东) | 2023-08-15 | — | — | CN | claimed |
| EP-1576093-A2 | 3-DEOXYGLUCOSONE AND SKIN | Dynamis Therapeutics, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| WO-2005079463-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | DYNAMIS THERAPEUTICS, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | DYNAMIS THERAPEUTICS, INC. | 2005-07-21 | — | — | US | claimed |
| WO-2003103832-A2 | OXYGEN REDUCTION CATALYST | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 2003-12-18 | — | — | WO | claimed |
| US-20030228972-A1 | Using cobalt containing coordination catalyst | UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC. (CA) | 2003-12-11 | — | — | US | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| US-6642170-B1 | Metals selected from tantalum, vanadium, niobium, chromium, molybdenum or tungsten on catalyst supports such as zeolites, oxides of silicon, aluminum, titanium, titanium, niobium or tantalum, used for etherification of alcohols-2+ | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2003-11-04 | — | — | US | claimed |
| WO-2003089601-A2 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| EP-0624088-A1 | AMINO ACIDS USEFUL AS INHIBITORS OF THE ADVANCED GLYCOSYLATION OF PROTEINS | THE ROCKEFELLER UNIVERSITY (US) | 1994-11-17 | — | — | EP | claimed |
| WO-1993014750-A2 | AMINO ACIDS USEFUL AS INHIBITORS OF THE ADVANCED GLYCOSYLATION OF PROTEINS | THE ROCKEFELLER UNIVERSITY (US) | 1993-08-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030219440-A1 | 3-deoxyglucosone and skin | DPM1, G6PD, UGGT1 | SLC7A5 1252/4885SLC1A3 695/4885SLC1A2 1649/4885 |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | AGER, GLA, GALE | SLC7A5 3617/4885SLC1A3 3950/4885SLC1A2 4728/4885 |
| US-12576169-B2 | Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof | KLK3, FOLH1, SLC7A1 | SLC7A5 10/4885SLC1A3 136/4885SLC1A2 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.